Filing metadata

Accession number
0001209191-20-060298
Form type
Form 4
Filer
Adamas Pharmaceuticals Inc
CIK
CIK 1328143
Filed
Nov 24, 2020
Reporting period
Nov 22, 2020
Description
Insider transaction

Explore SEC Filings Hub